Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: To whom it may concern:

 

Your guess is as good as any.  Buying shares on the open market shouldn't be an issue.  It's one way for PTSC to get a portion of their license fee. 

However, TPL is a private company and would want cash or equivilent for their share + expenses.

I'd like to see a large settlement.  Short of that LARGE settlement, bring on the trial.  The risk vs. reward ratio would seem to be on my side, but anything can happen in court and this is a speculative penny stock.

The next few days may be telling, one way or another.

John  

 

Share
New Message
Please login to post a reply